Hengbo Zhou - Concepedia

Author

Hengbo Zhou

University of Colorado Anschutz Medical Campus ORCID

Also Known As

H. Zhou, Hengbo Zhou, Lutz Menzel, Mårten Sandstedt, Zhou, Hengbo

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

University of Colorado Anschutz Medical Campus University of Colorado Denver Harvard University Georgetown University Massachusetts General Hospital

About

Hengbo Zhou is an author at University of Colorado Anschutz Medical Campus specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	364
2	Cell Biology	5	5	364
3	Immunology	2	2	128
4	Health Sciences	1	1	88
5	Natural Sciences	1	1	80

Hengbo Zhou

Publications

745

Citations

H-Index

Page 1

	Year	Citations
EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells Deepika Neelakantan, Hengbo Zhou, Michael Oliphant, Nature Communications	2017	179
VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk Deguang Kong, Hengbo Zhou, Deepika Neelakantan, Oncogene Breast OncologyMedicineVegf-c MediatesEpithelial-mesenchymal InteractionsCell Proliferation	2020	88
Solid stress impairs lymphocyte infiltration into lymph-node metastases Dennis Jones, Zixiong Wang, Ivy X. Chen, Nature Biomedical Engineering ImmunologyLymphatic SystemCell MigrationLymphatic DiseaseLymph-node Metastases	2021	81
Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression Lingdi Zhang, Hengbo Zhou, Xueni Li, Nature Communications Molecular RegulationTumor ProgressionMolecular BiologyCancer BiologyTumor Biology	2018	80
The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma Cynthia M. Simbulan‐Rosenthal, Sivanesan Dakshanamurthy, Anirudh Gaur, Oncotarget Repurposed Anthelmintic MebendazolePathologyStructure-based Drug RepositioningDermatologyTumor Biology	2017	68
Cancer cell plasticity and MHC-II–mediated immune tolerance promote breast cancer metastasis to lymph nodes Pin‐Ji Lei, Ethel R. Pereira, Patrik Andersson, The Journal of Experimental Medicine	2023	55
Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer Cells Jothi Anantharajan, Hengbo Zhou, Lingdi Zhang, Molecular Cancer Therapeutics	2019	53
Eya3 promotes breast tumor–associated immune suppression via threonine phosphatase–mediated PD-L1 upregulation Rebecca L. Vartuli, Hengbo Zhou, Lingdi Zhang, Journal of Clinical Investigation Pd-l1 UpregulationImmunologyImmune RegulationImmunotherapyCancer Biology	2018	47
Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and Metastasis Hengbo Zhou, Melanie A. Blevins, Jessica Y. Hsu, Cancer Research	2020	47
CD133 Is Associated with Increased Melanoma Cell Survival after Multikinase Inhibition Cynthia M. Simbulan‐Rosenthal, Anirudh Gaur, Hengbo Zhou, Journal of Oncology	2019	21

Page 1